Trial intelligence / Profile preview

Surfactant With and Without Budesonide for BPD in ELBW Infants

NCT01268215Phase 2Unknown

Sponsor
East Carolina University
Start
Jul 2010
Primary completion
Jun 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised trial of budesonide in bronchopulmonary dysplasia (BPD) (3 arms), sponsored by East Carolina University. Primary endpoint: Development of Bronchopulmonary Dysplasia. Status: unknown.

02

Drugs

budesonide
03

Conditions

bronchopulmonary dysplasia (BPD)

Beyond the preview

Go deeper on NCT01268215.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01268215.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call